Search Orphan Drug Designations and Approvals
-
Generic Name: | Pexastimogene Devacirepvec |
---|---|
Date Designated: | 09/14/2020 |
Orphan Designation: | Treatment of stage IIB-IV melanoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
SillaJen, Inc. 6F, 111, Hyoyeol-ro Suite 200 Buk-gu, Busan South Korea The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-